Association between LMP2/LMP7 genetic variability and the metastasis risk of ovarian cancer in Chinese women in Beijing

Human Immunology

Volumn 75, Issue 3, 2014, Pages 239-244

  Song, Li ^a   Ma, Nina ^b   Han, Lei ^a   Yan, Han ^b   Yan, Bo ^c   Yuan, Zhenyan ^b   Cao, Bangwei ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CARCINOMA; CHINA; CYSTEINE ENDOPEPTIDASES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; RISK;

EID: 84893766768     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.12.006     Document Type: Article

References (30)

1. Kohn E.C., Hurteau J. Ovarian cancer: making its own rules-again. Cancer 2013, 119:474-476. [PubMed:23233093].
2. Rosenblatt K.A., Weiss N.S., Cushing-Haugen K.L., Wicklund K.G., Rossing M.A. Genital powder exposure and the risk of epithelial ovarian cancer. Cancer Causes Control 2011, 22:737-742. [PubMed:21516319].
3. Mackay H.J., Brady M.F., Oza A.M., Reuss A., Pujade-Lauraine E., Swart A.M., et al. Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer. Int J Gynecol Cancer 2010, 20:945-952. [PubMed:20683400].
4. Nguyen L., Cardenas-Goicoechea S.J., Gordon P., Curtin C., Momeni M., Chuang L., et al. Biomarkers for early detection of ovarian cancer. Womens Health (Lond Engl) 2013, 9:171-187. [PubMed:23477323].
5. Zacharakis D., Thomakos N., Biliatis I., Rodolakis A., Simou M., Daskalakis G., et al. Ultrasonographic markers and preoperative CA-125 to distinguish between borderline ovarian tumors and stage I ovarian cancer. Acta Obstet Gynecol Scand 2013, 92:285-292. [PubMed:23193945].
6. Bruning-Richardson A., Bond J., Alsiary R., Richardson J., Cairns D.A., McCormack L., et al. ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival. Br J Cancer 2011, 104:1602-1610. [PubMed:21505456].
7. Morse M.A., Secord A.A., Blackwell K., Hobeika A.C., Sinnathamby G., Osada T., et al. MHC class I-presented tumor antigens identified in ovarian cancer by immunoproteomic analysis are targets for T-cell responses against breast and ovarian cancer. Clin Cancer Res 2011, 17:3408-3419. [PubMed:21300761].
8. Nesbeth Y.C., Martinez D.G., Toraya S., Scarlett U.K., Cubillos-Ruiz J.R., Rutkowski M.R., et al. CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells. J Immunol 2010, 184:5654-5662. [PubMed:20400704].
9. Cao B., Tian X., Li Y., Jiang P., Ning T., Xing H., et al. LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis 2005, 26:1280-1284. [PubMed:15774487].
10. Xu C., Qi S., Gao L., Cui H., Liu M., Yang H., et al. Genetic polymorphisms of LMP/TAP gene and hepatitis B virus infection risk in the Chinese population. J Clin Immunol 2007, 27:534-541. [PubMed:17525827].
11. Camarena A., Aquino-Galvez A., Falfan-Valencia R., Sanchez G., Montano M., Ramos C., et al. PSMB8 (LMP7) but not PSMB9 (LMP2) gene polymorphisms are associated to pigeon breeder's hypersensitivity pneumonitis. Respir Med 2010, 104:889-894. [PubMed:20153157].
12. Cabrera C.M., Jimenez P., Concha A., Garrido F., Ruiz-Cabello F. Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation. Tissue Antigens 2004, 63:446-452. [PubMed:15104675].
13. Dissemond J., Goette P., Moers J., Lindeke A., Goos M., Ferrone S., et al. Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regression. Melanoma Res 2003, 13:371-377. [PubMed:12883363].
14. Shen Y.Q., Zhang J.Q., Xia M., Miao F.Q., Shan X.N., Xie W. Low-molecular-weight protein (LMP)2/LMP7 abnormality underlies the downregulation of human leukocyte antigen class I antigen in a hepatocellular carcinoma cell line. J Gastroenterol Hepatol 2007, 22:1155-1161. [PubMed:17608862].
15. Giordano S. The 2008 Declaration of Helsinki: some reflections. J Med Ethics 2010, 36:598-603. [PubMed:20813718].
16. Cao B., Zhu L., Zhu S., Li D., Zhang C., Xu C., et al. Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer. Cancer Immunol Immunother 2010, 59:1851-1857. [PubMed:20811886].
17. Stephens M., Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003, 73:1162-1169. [PubMed:14574645].
18. Cao B., Liu X., Hou F., Li W., Han Z., Zhang Q., et al. The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a Chinese population. Liver Int 2009, 29:1383-1388. [PubMed:19744071].
19. Kilpivaara O., Aaltonen L.A. Diagnostic cancer genome sequencing and the contribution of germline variants. Science 2013, 339:1559-1562. [PubMed:23539595].
20. van Dorp W., van den Heuvel-Eibrink M.M., Stolk L., Pieters R., Uitterlinden A.G., Visser J.A., et al. Genetic variation may modify ovarian reserve in female childhood cancer survivors. Hum Reprod 2013, 28:1069-1076. [PubMed:23360674].
21. Basler M., Kirk C.J., Groettrup M. The immunoproteasome in antigen processing and other immunological functions. Curr Opin Immunol 2013, 25:74-80. [PubMed:23219269].
22. Hussong S.A., Roehrich H., Kapphahn R.J., Maldonado M., Pardue M.T., Ferrington D.A. A novel role for the immunoproteasome in retinal function. Invest Ophthalmol Vis Sci 2011, 52:714-723. [PubMed:20881299].
23. Singh A.V., Bandi M., Aujay M.A., Kirk C.J., Hark D.E., Raje N., et al. PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell growth both in vitro and in vivo. Br J Haematol 2011, 152:155-163. [PubMed:21114484].
24. Song D.G., Ye Q., Santoro S., Fang C., Best A., Powell D.J. Chimeric NKG2D CAR-expressing T Cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition. Hum Gene Ther 2013, 24:295-305. [PubMed:23297870].
25. de Graaf N., van Helden M.J., Textoris-Taube K., Chiba T., Topham D.J., Kloetzel P.M., et al. PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo. Eur J Immunol 2011, 41:926-935. [PubMed:21360704].
26. Cao B., Dong S., Su Q., Yan B., Zhen H., Yuan Z., et al. Lack of association between the unique LMP2 gene polymorphism and the outcome of lung cancer in a population of Chinese Han nationality. Hum Immunol 2012, 73:580-584. [PubMed:22261389].
27. Schmidt N., Gonzalez E., Visekruna A., Kuhl A.A., Loddenkemper C., Mollenkopf H., et al. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut 2010, 59:896-906. [PubMed: 20581238].
28. Ayshamgul H., Ma H., Ilyar S., Zhang L.W., Abulizi A. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer. Chin Med J (Engl) 2011, 124:341-346. [PubMed: 21362330].
29. Seliger B., Stoehr R., Handke D., Mueller A., Ferrone S., Wullich B., et al. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer. Cancer Immunol Immunother 2010, 59:529-540. [PubMed:19820934].
30. Fellerhoff B., Gu S., Laumbacher B., Nerlich A.G., Weiss E.H., Glas J., Kopp R., Johnson J.P., Wank R. The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer. Cancer Res 2011, 71:7145-7154. [PubMed:22037870].